PLUS THERAPEUTICS, INC. 8-K

What Happened

• Plus Therapeutics, Inc. (PSTV) filed an 8-K on March 12, 2026 announcing its 2026 Annual Meeting of Stockholders will be held virtually on Thursday, May 14, 2026 at 9:00 a.m. Eastern Time.
• Stockholders of record as of the close of business on March 18, 2026 will be entitled to notice of and to vote at the meeting. The company may change the record date, date, time or place prior to the meeting.
• Because the meeting date is more than 30 days before the anniversary of the 2025 meeting, previously stated deadlines in the 2025 proxy statement no longer apply; the company set new deadlines for shareholder proposals and director nominations.

Key Details

• Annual Meeting: Thursday, May 14, 2026 at 9:00 a.m. ET (virtual).
• Record date: Close of business on March 18, 2026.
• Deadlines for proposals and nominations: March 22, 2026 (Rule 14a-8 proposals and advance notice under the Bylaws; nominations must be delivered by 5:00 p.m. ET).
• Submission address: Corporate Secretary, 6420 Levit Green Boulevard, Suite 310, Houston, Texas 77021. Notice under Rule 14a-19 (universal proxy) must also be provided by March 22, 2026.
• Filing signed by Marc H. Hedrick, M.D., President and CEO, on March 12, 2026.

Why It Matters

• Investors who want to submit proposals or nominate director candidates must meet the new March 22, 2026 deadlines to be considered for inclusion in the company’s proxy materials or to comply with the Bylaws and SEC rules.
• Missing these deadlines means proposals or nominations will be untimely and may not appear in the proxy materials or be eligible for shareholder consideration.
• The virtual format and specified record date affect how shareholders participate and vote, so holders should confirm their record ownership status by March 18, 2026 if they plan to vote.